EU agency backs new drugs from Actelion and Lundbeck

European regulators have recommended approval of Swiss firm Actelion`s new pulmonary arterial hypertension drug Opsumit and a novel antidepressant called Brintellix from Denmark`s Lundbeck.

European Commission fines Ranbaxy and 8 other pharma firms

According to information available on the European Commission (EC) website, Ranbaxy Laboratories has been fined euro 10.32 million (over Rs 80 crore).

EU regulators may fine Ranbaxy and other drug makers

Reports said that Ranbaxy was among the nine companies that are to fined for the allegedly blocking the entry of the generic medicines in the EU.